Company intelligence / Profile preview

Topmed International Biotech

Taiwan

Ownership: Private
Development stage: Other

Overview

Topmed International Biotech is a Taiwan-based biotech company focused on commercialization and distribution of low-dose oral interferon-alpha biologic products for the animal health market, including VELDONA interferon-alpha for pets, under a distribution agreement with Ainos.

Therapeutic areas: ImmunologyInfectious Diseases
Modalities: BiologicProtein
Industry: Veterinary

Partnerships

Ainos

Beyond the preview

Go deeper on Topmed International Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Topmed International Biotech.

Explore the full profile